ODYY · Odyssey Health, Inc.
Market Cap
$908,717
Shares
100.97M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2020
Net Income
-$1.74M
-106.9%
FY2025
Gross Margin
45.8%
+34.6pp
FY2016
Operating Margin
-196.43%
-135.8pp
FY2016
Diluted EPS
-$0.02
-100%
FY2025
Operating Cash Flow
-$347.39K
+71.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $0 | $0 | $0 | $0 | $37.45K | $257.22K | |
| — | — | — | — | — | — | $0 | $0 | $0 | $0 | $20.3K | $228.49K | |
| — | — | — | — | — | — | $0 | $0 | $0 | $0 | $17.15K | $28.73K | |
| — | — | — | — | — | — | — | — | — | — | 45.8% | 11.17% | |
| — | $0 | $55.17K | $201.33K | $1.32M | $1.63M | $20.24K | $23.01M | — | — | — | — | |
| $938.36K | $1.02M | $2.08M | $2.12M | $2.92M | $4.79M | $3.85M | $23.36M | $289K | $167.58K | $90.72K | $184.63K | |
| — | — | $1538 | $3416 | — | — | — | $40.83K | $10K | — | — | — | |
| $0 | — | $1538 | $3416 | $3416 | $2374 | $10.55K | $10.55K | $10.55K | $10.55K | $5138 | $0 | |
| -$938.36K | -$1.02M | -$2.14M | -$5.31M | -$8.11M | -$15.86M | -$3.85M | -$23.58M | -$420.44K | -$167.58K | -$73.57K | -$155.9K | |
| — | — | — | — | — | — | — | — | — | — | -196.43% | -60.61% | |
| -$1.13M | — | -$2.14M | -$5.31M | -$8.1M | -$15.86M | -$3.84M | -$23.57M | -$409.89K | -$157.02K | -$68.43K | -$155.9K | |
| $1.09M | $252.52K | $518.48K | $614.08K | $836.29K | $1.07M | $502.19K | $70.28K | $62.67K | $30.27K | $12.55K | $4800 | |
| -$20.14K | -$10.01K | $9265 | $8677 | — | — | — | — | — | — | — | — | |
| -$27.36K | -$459.42K | -$1.64M | — | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | |
| -$3.57M | -$1.74M | -$842.32K | -$5.92M | -$8.44M | -$16.88M | -$4.35M | -$23.43M | -$483.12K | -$197.84K | -$86.12K | -$160.7K | |
| — | — | — | — | — | — | — | — | — | — | -229.94% | -62.47% | |
| — | -$1.74M | -$905.77K | -$5.92M | — | — | — | — | — | — | — | — | |
| USD/shares | -$0.03 | -$0.02 | -$0.01 | -$0.07 | -$0.09 | -$0.18 | -$0.05 | -$0.34 | $0.00 | $0.00 | $0.00 | $0.00 |
| USD/shares | -$0.03 | -$0.02 | -$0.01 | -$0.07 | -$0.09 | -$0.18 | — | — | — | — | — | — |
| shares | — | 104.71M | 97.06M | 82.68M | 89M | 93.73M | 87.12M | 69.9M | 117.13M | 114.79M | 114.75M | 114.75M |
| shares | — | 104.71M | 97.06M | 82.68M | 89M | 93.73M | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.36×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 28 similar-size Medical Devices companies (of 144 listed).